Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.European drug provider OctoPlus has signed a formulation development and manufacturing contract with Ferring Pharmaceuticals.
Subscribe to our email newsletter
OctoPlus will provide both formulation development and clinical material manufacturing services to biotech and pharmaceutical companies across the globe.
The undisclosed contract value is expected to make a material contribution to OctoPlus’ 2012 revenues.
Financial details on the compound and activities have not been disclosed.
OctoPlus is focused on the development and manufacture of improved injectable pharmaceuticals, long-acting, controlled release versions of known protein therapeutics, peptides and small molecules.